Galapagos wins $3.5M grant for antibiotics research

01/11/2013 | Genetic Engineering & Biotechnology News

A Flemish agency awarded Galapagos a grant worth about $3.5 million to discover new antibiotics. The firm will work with researchers from Ghent University and Free University Brussels in this three-year project. "With this grant, we can support the search for more novel inhibitors of the antibacterial target DNA pol III alpha to fight against these difficult-to-treat bacterial species," Galapagos chief scientific officer Piet Wigerinck said.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX